|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
1
Cardiovascular Division, Department of Medicine, University of Pennsylvania,
Philadelphia, PA 19104, USA
2
Department of Neurobiology, University of Pennsylvania, Philadelphia, PA
19104, USA
*
Author for correspondence (e-mail:
epsteinj{at}mail.med.upenn.edu
)
Accepted 30 March 2001
Classic studies using avian model systems have demonstrated that cardiac neural crest cells are required for proper development of the cardiovascular system. Environmental influences that perturb neural crest development cause congenital heart defects in laboratory animals and in man. However, little progress has been made in determining molecular programs specifically regulating cardiac neural crest migration and function. Only recently have complex transgenic tools become available that confirm the presence of cardiac neural crest cells in the mammalian heart. These studies have relied upon the use of transgenic mouse lines and fate-mapping studies using Cre recombinase and neural crest-specific promoters. In this study, we use these techniques to demonstrate that PlexinA2 is expressed by migrating and postmigratory cardiac neural crest cells in the mouse. Plexins function as co-receptors for semaphorin signaling molecules and mediate axon pathfinding in the central nervous system. We demonstrate that PlexinA2-expressing cardiac neural crest cells are patterned abnormally in several mutant mouse lines with congenital heart disease including those lacking the secreted signaling molecule Semaphorin 3C. These data suggest a parallel between the function of semaphorin signaling in the central nervous system and in the patterning of cardiac neural crest in the periphery.
Key words: Neural crest, Heart, Semaphorin, Plexin, Mouse
This article has been cited by other articles:
|
|
 |
|
  M. L. Kirby Pulmonary Atresia or Persistent Truncus Arteriosus: Is It Important to Make the Distinction and How Do We Do It? Circ. Res., August 15, 2008; 103(4): 337 - 339. [Full Text] [PDF]
|
|
|
|
|
|
F. A. Ismat, M. Zhang, H. Kook, B. Huang, R. Zhou, V. A. Ferrari, J. A. Epstein, and V. V. Patel Homeobox Protein Hop Functions in the Adult Cardiac Conduction System Circ. Res., April 29, 2005; 96(8): 898 - 903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Baldwin Only Our Patients Know for Sure Circ. Res., June 11, 2004; 94(11): 1401 - 1402. [Full Text] [PDF]
|
|
|
|
|
|
P. J. Gruber and J. A. Epstein Development Gone Awry: Congenital Heart Disease Circ. Res., February 20, 2004; 94(3): 273 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Hamblet, N. Lijam, P. Ruiz-Lozano, J. Wang, Y. Yang, Z. Luo, L. Mei, K. R. Chien, D. J. Sussman, and A. Wynshaw-Boris Dishevelled 2 is essential for cardiac outflow tract development, somite segmentation and neural tube closure Development, March 14, 2003; 129(24): 5827 - 5838. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. C. Delot, M. E. Bahamonde, M. Zhao, and K. M. Lyons BMP signaling is required for septation of the outflow tract of the mammalian heart Development, January 1, 2003; 130(1): 209 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Liu, W. Liu, J. Palie, M. F. Lu, N. A. Brown, and J. F. Martin Pitx2c patterns anterior myocardium and aortic arch vessels and is required for local cell movement into atrioventricular cushions Development, January 11, 2002; 129(21): 5081 - 5091. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Feiner, A. L. Webber, C. B. Brown, M. M. Lu, L. Jia, P. Feinstein, P. Mombaerts, J. A. Epstein, and J. A. Raper Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption Development, August 15, 2001; 128(16): 3061 - 3070. [Abstract] [Full Text] [PDF]
|
|
